Answers are grounded in this paper and cite their sources.
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis-a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries' ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them.
No takes yet. Share an insight, caveat, or question.
Rainima-Qaniuci et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: